1. Home
  2. RGNT vs RDI Comparison

RGNT vs RDI Comparison

Compare RGNT & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.28

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

RDI

Reading International Inc

HOLD

Current Price

$1.09

Market Cap

23.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNT
RDI
Founded
2004
1937
Country
Israel
United States
Employees
N/A
2025
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
23.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGNT
RDI
Price
$3.28
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.0K
22.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$0.94
52 Week High
$8.35
$1.65

Technical Indicators

Market Signals
Indicator
RGNT
RDI
Relative Strength Index (RSI) 29.00 51.96
Support Level N/A $1.07
Resistance Level $4.40 $1.16
Average True Range (ATR) 0.24 0.06
MACD 0.03 0.01
Stochastic Oscillator 13.46 74.36

Price Performance

Historical Comparison
RGNT
RDI

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: